ZenaTech Unveils Low‑Cost Interceptor P‑1 Drone for Counter‑UAS Operations

ZENA
March 17, 2026

ZenaTech, a U.S. defense technology company, announced the development of the Interceptor P‑1, a low‑cost, expendable, autonomous VTOL drone designed to physically intercept hostile unmanned aircraft.

The Interceptor P‑1 is part of ZenaTech’s broader counter‑UAS strategy, which includes the ZenaDrone 2000 and IQ Glider launch station. The company positions the new drone as a cost‑effective alternative to traditional air defense systems, targeting procurement by allied governments, NATO partners, and Gulf Cooperation Council defense customers.

ZenaTech’s market capitalization stands at $121 million, and the stock has fallen 60 % over the past six months. The company’s revenue grew 321 % in the last twelve months, but it is not expected to be profitable this year and is burning through cash at a rapid pace. Gross profit has dropped 178 % YoY and gross margin has shrunk 119 % YoY, indicating significant margin compression.

CEO Shaun Passley said, "The drone threat on modern battlefields is accelerating faster than legacy defense budgets can absorb. Our Interceptor‑P1 is being developed to give military and security forces an affordable, scalable answer by creating an interceptor and anti‑drone system for a new world of asymmetric warfare."

The counter‑UAS market is projected to exceed $10 billion by 2030, growing at a CAGR of over 25 %. ZenaTech competes with major defense contractors such as Lockheed Martin, RTX, Northrop Grumman, BAE Systems, and Thales. By offering a lower‑cost solution, ZenaTech seeks to capture a share of the market that is increasingly focused on affordable, layered counter‑drone capabilities.

While the Interceptor P‑1 represents a strategic product development, investors remain cautious due to the company’s financial fragility. The announcement underscores ZenaTech’s ambition to expand its Drone as a Service operations and to integrate AI and quantum navigation technologies, but the company’s ability to translate the new product into revenue and profitability remains uncertain.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.